Synold TW - Search Results

1

The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux.

Synold TW, Dussault I, Forman BM. Synold TW, et al. Nat Med. 2001 May;7(5):584-90. doi: 10.1038/87912. Nat Med. 2001. PMID: 11329060

2

Antineoplastic activity of continuous exposure to dexrazoxane: potential new role as a novel topoisomerase II inhibitor.

Synold TW, Tetef ML, Doroshow JH. Synold TW, et al. Semin Oncol. 1998 Aug;25(4 Suppl 10):93-9. Semin Oncol. 1998. PMID: 9768830 Clinical Trial.

3

Cellular but not plasma pharmacokinetics of lometrexol correlate with the occurrence of cumulative hematological toxicity.

Synold TW, Newman EM, Carroll M, Muggia FM, Groshen S, Johnson K, Doroshow JH. Synold TW, et al. Clin Cancer Res. 1998 Oct;4(10):2349-55. Clin Cancer Res. 1998. PMID: 9796964

4

A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A.

Raschko JW, Synold TW, Chow W, Coluzzi P, Hamasaki V, Leong LA, Margolin KA, Morgan RJ, Shibata SI, Somlo G, Tetef ML, Yen Y, ter Veer A, Doroshow JH. Raschko JW, et al. Among authors: synold tw. Cancer Chemother Pharmacol. 2000;46(5):403-10. doi: 10.1007/s002800000142. Cancer Chemother Pharmacol. 2000. PMID: 11127945 Clinical Trial.

5

Peptide mimetic HIV protease inhibitors are ligands for the orphan receptor SXR.

Dussault I, Lin M, Hollister K, Wang EH, Synold TW, Forman BM. Dussault I, et al. Among authors: synold tw. J Biol Chem. 2001 Sep 7;276(36):33309-12. doi: 10.1074/jbc.C100375200. Epub 2001 Jul 20. J Biol Chem. 2001. PMID: 11466304

6

Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics.

Morgan RJ Jr, Doroshow JH, Synold T, Lim D, Shibata S, Margolin K, Schwarz R, Leong L, Somlo G, Twardowski P, Yen Y, Chow W, Lin P, Paz B, Chu D, Frankel P, Stalter S. Morgan RJ Jr, et al. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5896-901. Clin Cancer Res. 2003. PMID: 14676112 Clinical Trial.

7

Neurophysiological study of peripheral neuropathy after high-dose Paclitaxel: lack of neuroprotective effect of amifostine.

Openshaw H, Beamon K, Synold TW, Longmate J, Slatkin NE, Doroshow JH, Forman S, Margolin K, Morgan R, Shibata S, Somlo G. Openshaw H, et al. Among authors: synold tw. Clin Cancer Res. 2004 Jan 15;10(2):461-7. doi: 10.1158/1078-0432.ccr-0772-03. Clin Cancer Res. 2004. PMID: 14760066

8

CCI-779 in metastatic melanoma: a phase II trial of the California Cancer Consortium.

Margolin K, Longmate J, Baratta T, Synold T, Christensen S, Weber J, Gajewski T, Quirt I, Doroshow JH. Margolin K, et al. Cancer. 2005 Sep 1;104(5):1045-8. doi: 10.1002/cncr.21265. Cancer. 2005. PMID: 16007689 Clinical Trial.

9

The effect of height on paclitaxel nerve damage.

Openshaw H, Beamon K, Longmate J, Synold T, Slatkin NE, Somlo G. Openshaw H, et al. J Neurooncol. 2005 Sep;74(2):207-10. doi: 10.1007/s11060-004-6599-6. J Neurooncol. 2005. PMID: 16193394

10

A new model for studying tissue-specific mdr1a gene expression in vivo by live imaging.

Gu L, Tsark WM, Brown DA, Blanchard S, Synold TW, Kane SE. Gu L, et al. Among authors: synold tw. Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5394-9. doi: 10.1073/pnas.0807343106. Epub 2009 Mar 12. Proc Natl Acad Sci U S A. 2009. PMID: 19282474 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results